Viz HCM vs KardiaPro
AI Verdict
Choose Viz HCM if…
Choose Viz HCM if your healthcare system needs an AI-powered solution for real-time, system-wide screening of 12-lead ECGs to detect suspected Hypertrophic Cardiomyopathy (HCM) and rapidly coordinate specialized cardiac care. This tool is ideal for hospitals aiming to significantly reduce HCM diagnosis time and streamline workflows by automatically alerting multidisciplinary care teams and directing patients to appropriate specialists.
View Viz HCM →Choose KardiaPro if…
Choose KardiaPro if you require a comprehensive, web-based platform for remote patient monitoring of ECG, blood pressure, and weight data, particularly for ongoing management of arrhythmias and other cardiac conditions between appointments. This tool is best suited for healthcare professionals who need to efficiently review and analyze longitudinal cardiac trends from compatible personal ECG devices like KardiaMobile, enabling informed clinical decisions and supporting remote patient management.
View KardiaPro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz HCMViz HCM offers real-time AI analysis of 12-lead ECGs and mobile-based alerts, streamlining workflows and providing comprehensive patient views with EMR integration. KardiaPro, while offering a web-based portal and customizable inbox, relies on patient-recorded ECGs from external devices, which may introduce an extra step in the workflow compared to Viz HCM's automated system.
Clinical Value
Viz HCMViz HCM is specifically designed for the detection of Hypertrophic Cardiomyopathy (HCM), a condition often undiagnosed, and has demonstrated success in identifying new HCM patients and reducing diagnosis time through AI-powered ECG analysis and care coordination. KardiaPro focuses on remote monitoring for various arrhythmias and general cardiac data, which is valuable but less specialized than Viz HCM's targeted approach to a specific, often-missed disease.
Pricing & Value
Viz HCMViz HCM has clear information regarding CMS reimbursement for specific CPT codes, effective January 1, 2025, providing a tangible financial benefit for hospitals and health systems. KardiaPro states it is reimbursable using existing CPT codes, but does not provide specific codes or national payment rates, making its financial value less transparent.
Enterprise Readiness
Viz HCMViz HCM is a cloud-based platform integrated into hospital IT systems (EHR, PACS) and is deployed in 2,000 U.S. hospitals, indicating strong enterprise adoption and integration capabilities. KardiaPro is also cloud-hosted and web-based, with stated EHR/third-party interoperability, but lacks the specific scale of deployment seen with Viz HCM.
Innovation
Viz HCMViz HCM received De Novo FDA approval, establishing a new regulatory category for cardiovascular machine learning-based notification software, highlighting its pioneering innovation in AI for HCM detection. While KardiaPro utilizes FDA-cleared AI for arrhythmia detection and remote monitoring, its core technology has been around longer, with its initial AI platform for AF detection released in 2017.
Support & Docs
TieBoth tools offer accessible support and documentation. Viz.ai provides a knowledge base with FAQs, troubleshooting, and contact information. AliveCor offers a KardiaPro support portal with user guides, FAQs, and contact details via phone and email. Without further specific metrics on response times or comprehensiveness, it's difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz HCM | KardiaPro |
|---|---|---|
| Tool Name | Viz HCM | KardiaPro |
| Company | Viz.ai | AliveCor |
| Description | FDA-cleared AI tool that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time. | Comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations. |
| Primary AI Focus | Hypertrophic Cardiomyopathy (HCM) detection from ECG analysis | Arrhythmia detection from ECG |
| Reimbursement | CMS reimbursement available for CPT codes 0764T and 0765T (national payment rate $128.90, effective Jan 1, 2025) | Reimbursable using existing CPTu00ae codes |
| Key Data Managed | Real-time ECG analysis for HCM detection | ECG, blood pressure, and weight data |
| Integration Capabilities | Seamless integration with existing clinical workflows, EHR, and PACS systems | Seamless integration with KardiaMobile and KardiaMobile 6L devices; Integration with KardiaStation for point-of-care solutions |
Videos
Demos, reviews, and walkthroughs featuring Viz HCM and KardiaPro.
More Comparisons
More matchups featuring Viz HCM or KardiaPro
Backers
Who funded each tool's parent company.